Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Trial of Lapatinib for the Treatment of Women With DCIS Breast Cancer

NCT00555152 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00555152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00555152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Trial of Lapatinib for the Treatment of Women With DCIS Breast Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Not applicable
Overall status
Completed
Start date
August 19, 2009
Completion date
August 28, 2014
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, her2/neu positive